Editas Medicine to Host Conference Call Discussing Third Quarter 2022 Results and Corporate Update

Rhea-AI Summary

Editas Medicine, a clinical-stage genome editing company, will host a conference call on November 2, 2022, at 8:00 a.m. ET to discuss its third-quarter results. U.S. callers can dial 877-407-0989, while international participants can call 201-389-0921. The call will also be available via webcast on the company's website, with a replay accessible after the call. Editas Medicine specializes in developing transformative genomic medicines utilizing CRISPR technology.

CAMBRIDGE, Mass., Oct. 26, 2022 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical stage genome editing company, today announced that it will host a conference call and webcast on Wednesday, November 2, 2022, at 8:00 a.m. ET to provide a corporate update and results for the third quarter of 2022.

To access the conference call:

• U.S. callers should dial 877-407-0989 and international callers should dial 201-389-0921 approximately five minutes before the call begins.
• Participants should ask to be connected to the Editas Medicine Earnings Conference Call.
  

The conference call will also be webcast and can be accessed from the “Investors” section of the Editas Medicine website at https://www.editasmedicine.com. A replay of the call will be available at the same site approximately one hour after the completion of the call.

About Editas Medicine
As a clinical stage genome editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a genome editing systems into a robust pipeline of treatments for people living with serious diseases around the world. Editas Medicine aims to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases. Editas Medicine is the exclusive licensee of Broad Institute and Harvard University’s Cas9 patent estates and Broad Institute’s Cas12a patent estate for human medicines. For the latest information and scientific presentations, please visit www.editasmedicine.com. 

Media Contact:
Cristi Barnett
(617) 401-0113
cristi.barnett@editasmed.com 

Investor Contact:
Ron Moldaver
(617) 401-9052
ir@editasmed.com 

FAQ

When is the Editas Medicine conference call scheduled?

The Editas Medicine conference call is scheduled for November 2, 2022, at 8:00 a.m. ET.

How can I access the Editas Medicine conference call?

You can access the Editas Medicine conference call by dialing 877-407-0989 for U.S. callers and 201-389-0921 for international callers.

Where can I watch the Editas Medicine conference call webcast?

The Editas Medicine conference call webcast can be watched on their official website in the 'Investors' section.

What is the purpose of the Editas Medicine conference call?

The conference call will provide a corporate update and discuss the results for the third quarter of 2022.

Is there a replay available for the Editas Medicine conference call?

Yes, a replay of the Editas Medicine conference call will be available on their website approximately one hour after the call ends.